Keyword "ENDOTOXIN" found in the following publications:

• PHARMACOLOGICAL EFFICIENCY OF STATINS AND L-NORVALIN AT AN ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION

  In the animals with endotoxin-induced endothelial dysfunction there were imbalance of contractile response of vessels wall observes when carrying out ...

  Abstract | Full text (PDF)

• PRACTICAL ASPECTS OF THE ANALYSIS OF PHARMACEUTICAL SUBSTANCES BY THE INDICATOR «BACTERIAL ENDOTOXINS»

  Background: Safety is one of the basic medicine requirements. «Bacterial endotoxins» is the most important safety indicator of parenteral ...

  Abstract | Full text (PDF)

• CONCOMITANT USE OF STATINS AND S-(2-BORON-ETHYL)-L-CYSTEINE ARGINASE INHIBITOR TO CORRECT ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION

  The concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor with simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of ...

  Abstract | Full text (PDF)

• LIPID DISTRESS-SYNDROME AND PROSPECTS OF ITS CORRECTION BY STATINES

  Endothelial dysfunction in peritonitis: The formed concept of lipid distress syndrome (LDS) allows us to develop a working hypothesis ...

  Abstract | Full text (PDF)

• ENDOTHELIO-AND CARDIOPROTECTIVE EFFECTS OF HMG-CO-A REDUCTASE IN ENDOTOKSIN-INDUCING ENDOTELIAL DYSFUNCTION

  The use of inhibitors of HMG-Co-A reductase inhibitor Simvastatin, Atorvastatin, Rosuvastatin and nanoparticulated Rosuvastatin on the background modeling of endotoxin-induced ...

  Abstract | Full text (PDF)

• ENDOTHELIUM AND CARDIOPROTECTIVE EFFECTS OF HMG-CO-A-REDUCTASE IN COMBINATION WITH L-ARGININE IN ENDOTHELIAL DYSFUNCTION MODELING

  Abstract. Using the combined application of L-arginine with HMG-Co-A reductase inhibitors simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background ...

  Abstract | Full text (PDF)